Omega Healthcare Investors, Inc. – Consensus ‘hold’ rating and -2.4% Downside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Omega Healthcare Investors, Inc. with ticker code (OHI) have now 14 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between 36 and 28 calculating the average target price we see $32.61. Given that the stocks previous close was at $33.40 this indicates there is a potential downside of -2.4%. It’s also worth noting that there is a 50 day moving average of $31.78 while the 200 day moving average is $29.33. The market capitalization for the company is 8.30B. The current share price for the company is: 32.94 USD

The potential market cap would be $8,099,556,294 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 31.98, revenue per share of 3.63 and a 2.33% return on assets.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company’s core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company’s portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search